Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
R/R CLL Treated With Fixed-Duration Pirtobrutinib Combined With Venetoclax ± Rituximab: Updated BRUIN Study Results Including MRD Data
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nirav Shah
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nirav Shah
Comments 0
Login to view comments.
Click here to Login
